NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
O-GlcNAcylation is a dynamic post-translational modification that regulates diverse cellular processes by modifying nuclear and cytoplasmic proteins in response to metabolic cues. This modification is controlled by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), which together maintain O-GlcNAc cycling. Emerging evidence indicates that O-GlcNAcylation plays a critical role in modulating neuroinflammation, a key pathological feature of many neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. O-GlcNAcylation modulates several components of the neuroinflammatory cascade, including glial activation, cytokine production, oxidative stress, and inflammasome assembly, primarily through its influence on transcription factors such as NF-κB and STATs, as well as key signaling pathways like MAPK. In this review, we critically evaluate current insights into the mechanisms by which O-GlcNAc cycling regulates neuroinflammatory processes and discuss recent advances in therapeutic strategies targeting O-GlcNAc metabolism. These insights underscore the potential of modulating O-GlcNAcylation as a novel strategy for controlling neuroinflammation across a range of disease contexts.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.